Clinicopathologic correlates of common cancer pain syndromes

A. Caraceni

doi:10.1016/S0889-8588(05)70327-0

Clinicopathologic correlates of common cancer pain syndromes

A. Caraceni

Fondazione IRCCS Istituto Nazionale dei Tumori

Research output: Contribution to journal › Article › peer-review

Abstract

The development of a treatment strategy for the management of cancer pain is based on a patient evaluation that elucidates the pain syndrome and predominant pathophysiologic mechanism responsible for the pain. Coupled with evaluation of pain intensity, and the extent of functional and emotional disturbance, this assessment facilitates appropriate selection of primary and analgesic therapies to address the problem of patient distress.

Original language	English
Pages (from-to)	57-78
Number of pages	22
Journal	Hematology/Oncology Clinics of North America
Volume	10
Issue number	1
DOIs	https://doi.org/10.1016/S0889-8588(05)70327-0
Publication status	Published - 1996

ASJC Scopus subject areas

Oncology
Hematology

Access to Document

10.1016/S0889-8588(05)70327-0

Cite this

@article{8d042fbe8c03458b95c3194f8e155647,

title = "Clinicopathologic correlates of common cancer pain syndromes",

abstract = "The development of a treatment strategy for the management of cancer pain is based on a patient evaluation that elucidates the pain syndrome and predominant pathophysiologic mechanism responsible for the pain. Coupled with evaluation of pain intensity, and the extent of functional and emotional disturbance, this assessment facilitates appropriate selection of primary and analgesic therapies to address the problem of patient distress.",

author = "A. Caraceni",

year = "1996",

doi = "10.1016/S0889-8588(05)70327-0",

language = "English",

volume = "10",

pages = "57--78",

journal = "Hematology/Oncology Clinics of North America",

issn = "0889-8588",

publisher = "W.B. Saunders Ltd",

number = "1",

}

TY - JOUR

T1 - Clinicopathologic correlates of common cancer pain syndromes

AU - Caraceni, A.

PY - 1996

Y1 - 1996

N2 - The development of a treatment strategy for the management of cancer pain is based on a patient evaluation that elucidates the pain syndrome and predominant pathophysiologic mechanism responsible for the pain. Coupled with evaluation of pain intensity, and the extent of functional and emotional disturbance, this assessment facilitates appropriate selection of primary and analgesic therapies to address the problem of patient distress.

AB - The development of a treatment strategy for the management of cancer pain is based on a patient evaluation that elucidates the pain syndrome and predominant pathophysiologic mechanism responsible for the pain. Coupled with evaluation of pain intensity, and the extent of functional and emotional disturbance, this assessment facilitates appropriate selection of primary and analgesic therapies to address the problem of patient distress.

UR - http://www.scopus.com/inward/record.url?scp=0030043149&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030043149&partnerID=8YFLogxK

U2 - 10.1016/S0889-8588(05)70327-0

DO - 10.1016/S0889-8588(05)70327-0

M3 - Article

C2 - 8821560

AN - SCOPUS:0030043149

VL - 10

SP - 57

EP - 78

JO - Hematology/Oncology Clinics of North America

JF - Hematology/Oncology Clinics of North America

SN - 0889-8588

IS - 1

ER -

Clinicopathologic correlates of common cancer pain syndromes

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this